Anti-diabetic effects of TongGuanWan, a chinese traditional herbal formula, in C57BL/KsJ-db/db mice

Planta Medica

Volumn 78, Issue 1, 2012, Pages 18-23

  Tang, Yi Hong ^a,b   Sun, Zhao Lin ^a   Fan, Ming Song ^a   Li, Zhi Xiong ^a   Huang, Cheng Gang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SHANGHAI INSTITUTE OF TECHNOLOGY   (China)

Author keywords

anti diabetic effect; herbal formula; TongGuanWan; type 2 diabetes

Indexed keywords

BERBERINE; CINNAMALDEHYDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MANGIFERIN; ROSIGLITAZONE; SAPONIN DERIVATIVE; TIMOSAPONIN AIII; TIMOSAPONIN BII; TONGGUANWAN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CHEMICAL COMPOSITION; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIODE ARRAY AND EVAPORATIVE LIGHT SCATTERING DETECTOR; DRUG EFFICACY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT EMITTING DIODE; LIGHT SCATTERING; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ACROLEIN; ADMINISTRATION, ORAL; ANIMALS; BERBERINE; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL, HDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; DRUGS, CHINESE HERBAL; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; PHYTOTHERAPY; SAPONINS; THIAZOLIDINEDIONES; TRIGLYCERIDES; XANTHONES;

ANIMALIA; MUS;

EID: 84855715156     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0031-1280268     Document Type: Article

References (21)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 1047-1053 (Pubitemid 38579764)
2. Media Center/Diabetes. Available at http://www.who.int/mediacentre/ factsheets/fs312/en/index.html Accessed August 1, 2008
3. Skyler J S. Diabetes mellitus: pathogenesis and treatment strategies. J Med Chem 2004 47 4113-4117 (Pubitemid 39045414)
4. Davis S N., Granner D K. Insulin, oral hypoglycemia agents and the pharmacology of the endocrine pancreas. In: Joel G H. Lee E editors Goodman & Gilman's the pharmacological basis of therapeutics. New York McGraw-Hill 1996 1679-1714
5. Jia W, Gao W, Ta L. Antidiabetic herbal drugs officially approved in China. Phytother Res 2003 17 1127-1134 (Pubitemid 38057166)
6. Kim J O., Lee G D., Kwon J H., Kim K S. Anti-diabetic effects of new herbal formula in neonatally streptozotocin-induced diabetic rats. Biol Pharm Bull 2009 32 421-426
7. Miura T, Ichiki H, Iwamoto N, Kato M, Kubo M, Sasaki H, Okada M, Ishida T, Seino Y, Tanigawa K. Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside. Biol Pharm Bull 2001 24 1009-1011 (Pubitemid 32894119)
8. Kim H J., Kong M K., Kim Y C. Beneficial effects of Phellodendri Cortex extract on hyperglycemia and diabetic nephropathy in streptozotocin-induced diabetic rats. BMB Rep 2008 41 710-715
9. Liu W H., Hei Z Q., Nie H, Tang F T., Huang H Q., Li X J., Deng Y H., Chen S R., Guo F F., Huang W G., Chen F Y., Liu P Q. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J 2008 121 706-712
10. Kwon K B., Kim E K., Jeong E S., Lee Y H., Lee Y R., Park J W., Ryu D G., Park B H. Cortex Cinnamomi extract prevents streptozotocin- and cytokine-induced -cell damage by inhibiting NF- B. World J Gastroenterol 2006 12 4331-4337
11. Chen H, Charlat O, Tartaglia L A., Woolf E A., Weng X, Ellis S J., Lakey N D., Culpepper J, Moore K J., Breitbart R E., Duyk G M., Tepper R I., Morgenstern J P. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996 84 491-495 (Pubitemid 26060722)
12. Gerich J E. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 2003 163 1306-1316 (Pubitemid 36676195)
13. Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice. Diabetes Obes Metab 2007 9 879-888 (Pubitemid 47555209)
14. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 2001 276 41245-41254
15. Bastard J P., Maachi M, Lagathu C, Kim M J., Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006 17 4-12
16. Villareal D T., Banks M R., Patterson B W., Polonsky K S., Klein S. Weight loss therapy improves pancreatic endocrine function in obese older adults. Obesity (Silver Spring) 2008 16 1349-1354 (Pubitemid 351770521)
17. Ikeoka D, Krusinova E. Insulin resistance and lipid metabolism. Rev Assoc Med Bras 2009 55 234
18. Chinese Pharmacopoeia. Part 1. Beijing Beijing: China Medical Science and Technology Press 2010 127 197, 286
19. Sellamuthu P S., Muniappan B P., Perumal S M., Kandasamy M. Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Health Sci 2009 55 206-214
20. Huang C G., Wang X L., Zhang Z Q., Shi S. Application of timosaponin A3 for preparing medicine for treating type 2 diabetes mellitus. CN Patent 02160151 2002
21. Awanish M, Rajbir B, Amarjit S, Mohan Paul S I. Ameliorative effect of the cinnamon oil from Cinnamomun zeylanicum upon early stage diabetic nephropathy. Planta Med 2010 76 412-417